Search Results - "Messner, HA"

Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument by Marras, T K, Szalai, J P, Chan, C K, Lipton, J H, Messner, H A, Laupacis, A

“…Pulmonary function testing (PFT) is used to characterize non-infectious pulmonary complications after allogeneic BMT. Identifying high-risk patients could…”
Get full text

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms by SUTHERLAND, H. J, FYLES, G. M, ADAMS, G, HAO, Y, LIPTON, J. H, MINDEN, M. D, MEHARCHAND, J. M, ATKINS, H, TEJPAR, I, MESSNER, H. A

“…All surviving patients who had received an allogeneic bone marrow transplant at the Princess Margaret Hospital were asked to participate in a health-related…”
Get full text

Long-term outcome of allogeneic transplants in acute myeloid leukemia by MESSNER, H. A

“…Leukemia (2002) 16, 751-752. DOI: 10.1038/sj/leu/2402463…”
Get full text

Prognostic implication of pre‐transplant FEV1 on long‐term outcomes following allogeneic hematopoietic stem cell transplantation by Novitzky‐Basso, Igor, Lam, Wilson, Chiarello, Caden, Pasic, Ivan, Law, Arjun D., Michelis, Fotios V., Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey H., Kumar, Rajat, Mattsson, Jonas, Messner, Hans A., Marras, Theodore K., Mittoo, Shikha, Kim, Dennis Dong Hwan

“…Background Pre‐transplant pulmonary function testing (PFT) is essential before allogeneic hematopoietic stem cell transplant (HCT), yet the optimal cutoff…”
Get full text

Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants : a Canadian perspective by COUBAN, S, DRANITSARIS, G, LIPTON, J, MEHARCHAND, J, MESSNER, H. A, ANDREOU, P, PRICE, S, TINKER, L, FOLEY, R, WALKER, I. R, JAMAL, S, JAMAL, N, SPANER, D

“…Allogeneic peripheral blood progenitor cell (PBPC) transplants are an alternative to BMT, although G-CSF mobilization dose, timing of pheresis and risk of GVHD…”
Get full text

Extended duration between harvest and re-infusion of human bone marrow stored at room temperature by LIPTON, J. H, JAMAL, N, MESSNER, H. A

“…A major limitation of unrelated bone marrow transplantation is the duration of time that is safe between harvest and re-infusion of the marrow. We have been…”
Get full text

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies by Couban, Stephen, Simpson, David R., Barnett, Michael J., Bredeson, Christopher, Hubesch, Lothar, Howson-Jan, Kang, Shore, Tsiporah B., Walker, Irwin R., Browett, Peter, Messner, Hans A., Panzarella, Tony, Lipton, Jeffrey H.

“…Cytokine-mobilized peripheral blood is increasingly used instead of bone marrow as the source of cells for allogeneic transplantation. Although cells lead to…”
Get full text

Multiple Single-Nucleotide Polymorphism―Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host Disease by KIM, Dennis, YUN, Jina, LIPTON, Jeffrey H, WON, Hong-Hee, LU CHENG, JIE SU, WEI XU, UHM, Jieun, GUPTA, Vikas, KURUVILLA, John, MESSNER, Hans A

“…We aimed to develop multiple single-nucleotide polymorphism (SNP)-based risk models associated with the risk of transplant outcomes including graft-versus-host…”
Get full text

A Randomized, Double-Blind Trial of Pneumococcal Vaccination in Adult Allogeneic Stem Cell Transplant Donors and Recipients by Kumar, Deepali, Chen, Maggie Hong, Welsh, Brenda, Siegal, Deborah, Cobos, Isabel, Messner, Hans A., Lipton, Jeff, Humar, Atul

“…Background.Adult allogeneic hematopoietic stem cell transplant (HSCT) recipients are at high risk of invasive pneumococcal disease but have suboptimal…”
Get full text

Stem cells: the challenge and opportunities by Messner, H A

“…Recent studies have clearly identified that hematopoietic stem cells (HSC) are part of a hierarchical organization defined by cells able to initiate long-term…”
Get full text

Current status of blood and marrow transplantation for patients with AML by Messner, H A

“…During the past decade it has become apparent that patients can be transplanted successfully after preparation with regimens of reduced intensity. Reduced…”
Get full text

Growth of Human Hemopoietic Colonies in Response to Recombinant Gibbon Interleukin 3: Comparison with Human Recombinant Granulocyte and Granulocyte--Macrophage Colony-Stimulating Factor by Messner, Hans A., Yamasaki, Kazuo, Jamal, Nazir, Minden, Mark M., Yang, Yu-Chung, Wong, Gordon G., Clark, Steven C.

“…Supernatants of COS-1 cells transfected with gibbon cDNA encoding interleukin 3 (IL-3) with homology to sequences for human IL-3 were tested for ability to…”
Get full text

The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin by XENOCOSTAS, Anargyros, CHEUNG, Wing K, MESSNER, Hans A, FARRELL, Francis, ZAKSZEWSKI, Cindy, KELLEY, Marian, LUTYNSKI, Andrzej, CRUMP, Michael, LIPTON, Jeffrey H, KISS, Thomas L, LAU, Catherine Y

“…Erythropoietin (EPO) was originally described as a regulator of erythropoiesis. Recently, synthesis of EPO and expression of the EPO receptor (EPO-R) have been…”
Get full text

Long-Term Medical Outcomes and Quality-of-Life Assessment of Patients With Chronic Myeloid Leukemia Followed at Least 10 Years After Allogeneic Bone Marrow Transplantation by KISS, T. L, ABDOLELL, M, JAMAL, N, MINDEN, LIPTON, J. H, MESSNER, H. A

“…Benchmark analysis of patients with chronic myeloid leukemia (CML) alive for more than 10 years after allogeneic bone marrow transplantation (BMT) including…”
Get full text

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project by Bennett, Charles L., Cournoyer, Denis, Carson, Kenneth R., Rossert, Jerome, Luminari, Stefano, Evens, Andrew M., Locatelli, Francesco, Belknap, Steven M., McKoy, June M., Lyons, E. Alison, Kim, Benjamin, Sharma, Rishi, Costello, Stacey, Toffelmire, Edwin B., Wells, George A., Messner, Hans A., Yarnold, Paul R., Trifilio, Steven M., Raisch, Dennis W., Kuzel, Timothy M., Nissenson, Allen, Lim, Lay-Cheng, Tallman, Martin S., Casadevall, Nicole

“…Since its introduction in 1988, recombinant human erythropoietin (epoetin) has been standard treatment for patients with anemia due to chronic kidney disease…”
Get full text

Long-term outcome of allogeneic transplants in acute myeloid leukemia by Messner, HA

“…What do we mean when we talk about the long-term outcome of bone marrow transplants for acute myeloid leukemia (AML)? The majority of studies present actuarial…”
Get full text

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation by HASEGAWA, W, POND, G. R, RIFKIND, J. T, MESSNER, H. A, LAU, A, DALY, A. S, KISS, T. L, KOTCHETKOVA, N, GALAL, A, LIPTON, J. H

“…The purpose of this study was to evaluate the estimated incidence of secondary malignancies post-allogeneic bone marrow transplantation (BMT) in a cohort of…”
Get full text

Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: Recommendations for minimization of risk by COURNOYER, Denis, TOFFELMIRE, Edwin B, PATTERSON, Bruce J, POON, Man-Chiu, POSEN, Gerald A, MESSNER, Hans A, WELLS, George A, BARBER, Dwayne L, BARRETT, Brendan J, DELAGE, Robert, FORREST, Donna L, GAGNON, Raymonde F, HARVEY, Elizabeth A, LANEUVILLE, Pierre

“…Since 1998, there has been a marked increase in incidence of pure red cell aplasia secondary to development of anti-erythropoietin antibodies (Ab+ PRCA) in…”
Get full text

A Possible Autocrine Role for Interleukin-6 in Two Lymphoma Cell Lines by Yee, Cassian, Biondi, A., Wang, X.H., Iscove, Norman N., Sousa, Jean de, Aarden, Lucien A., Wong, Gordon G., Clark, Steven C., Messner, Hans A., Minden, Mark D.

“…Interleukin-6 (IL-6) is a growth factor with diverse biologic activity. Originally described as a T-cell product that enhances immunoglobulin (Ig) secretion in…”
Get full text

Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation by MARRAS, T. K, CHAN, C. K, LIPTON, J. H, MESSNER, H. A, SZALAI, J. P, LAUPACIS, A

“…We studied long-term pulmonary function testing (PFT) in a retrospective cohort of 6-month survivors of allogeneic marrow transplant (BMT) between 1980 and…”
Get full text